4 flu Search Results


eidd 2749  (MedChemExpress)
94
MedChemExpress eidd 2749
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Eidd 2749, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/EIDD-2749/pmc13107972-20-0-3
Average 94 stars, based on 1 article reviews
eidd 2749 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier
core solution  (Chem Impex International)
95
Chem Impex International core solution
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Core Solution, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/4'-Hydroxyacetanilide/bio_rxiv__2025__04__03__647129-76-1-9
Average 95 stars, based on 1 article reviews
core solution - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier
glcnacβ1-3galβ-paa-flu  (GlycoTech Corporation)
90
GlycoTech Corporation glcnacβ1-3galβ-paa-flu
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Glcnacβ1 3galβ Paa Flu, supplied by GlycoTech Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/glcnac%CE%B21+4+glcnac%CE%B2++paa+flu++5+/us08383084-529-18-35
Average 90 stars, based on 1 article reviews
glcnacβ1-3galβ-paa-flu - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
flu vaccine 4 august  (Acambis Inc)
90
Acambis Inc flu vaccine 4 august
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Flu Vaccine 4 August, supplied by Acambis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/flu+vaccine+4+august/10__1086_slash_512206-41-0-8
Average 90 stars, based on 1 article reviews
flu vaccine 4 august - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
fluconazole (2, flu): 2-(2,4-difluorophenyl)-1,3-bis (1h-1,2,4-triazol-1-yl)propan-2-ol  (Shouguang Fukang Pharmaceutical Co Ltd)
90
Shouguang Fukang Pharmaceutical Co Ltd fluconazole (2, flu): 2-(2,4-difluorophenyl)-1,3-bis (1h-1,2,4-triazol-1-yl)propan-2-ol
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Fluconazole (2, Flu): 2 (2,4 Difluorophenyl) 1,3 Bis (1h 1,2,4 Triazol 1 Yl)propan 2 Ol, supplied by Shouguang Fukang Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/fluconazole++2++flu+++2++2+4+difluorophenyl++1+3+bis++1h+1+2+4+triazol+1+yl+propan+2+ol/10__1515_slash_chem___2022___0253-31-3-8
Average 90 stars, based on 1 article reviews
fluconazole (2, flu): 2-(2,4-difluorophenyl)-1,3-bis (1h-1,2,4-triazol-1-yl)propan-2-ol - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
real-time pcr assay abtestm flu 4 qpcr i kit (50) (v2.0)  (AITBIOTECH Pte Ltd)
90
AITBIOTECH Pte Ltd real-time pcr assay abtestm flu 4 qpcr i kit (50) (v2.0)
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Real Time Pcr Assay Abtestm Flu 4 Qpcr I Kit (50) (V2.0), supplied by AITBIOTECH Pte Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/real+time+pcr+assay+abtestm+flu+4+qpcr+i+kit++50+++v2+0+/pmc06450629-110-28-39
Average 90 stars, based on 1 article reviews
real-time pcr assay abtestm flu 4 qpcr i kit (50) (v2.0) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
flu ns_esat 6 and tb10.4 pilot batches containing 15% montanide gel adjuvant  (SEPPIC Inc)
90
SEPPIC Inc flu ns_esat 6 and tb10.4 pilot batches containing 15% montanide gel adjuvant
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Flu Ns Esat 6 And Tb10.4 Pilot Batches Containing 15% Montanide Gel Adjuvant, supplied by SEPPIC Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/flu+ns+esat+6+and+tb10+4+pilot+batches+containing+15++montanide+gel+adjuvant/pm37515015-28-30-33
Average 90 stars, based on 1 article reviews
flu ns_esat 6 and tb10.4 pilot batches containing 15% montanide gel adjuvant - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
inhaled 4-in-1 flu vaccine  (AstraZeneca ltd)
90
AstraZeneca ltd inhaled 4-in-1 flu vaccine
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Inhaled 4 In 1 Flu Vaccine, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/inhaled+4+in+1+flu+vaccine/pm24691877-755-13-2
Average 90 stars, based on 1 article reviews
inhaled 4-in-1 flu vaccine - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
fluxapyroxad [3-(difluoromethyl)-1-methyl-n-(3′,4′,5′trifluorobiphenyl-2-yl) pyrazole-4-carboxamide, flu]  (Dr Ehrenstorfer GmbH)
90
Dr Ehrenstorfer GmbH fluxapyroxad [3-(difluoromethyl)-1-methyl-n-(3′,4′,5′trifluorobiphenyl-2-yl) pyrazole-4-carboxamide, flu]
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Fluxapyroxad [3 (Difluoromethyl) 1 Methyl N (3′,4′,5′Trifluorobiphenyl 2 Yl) Pyrazole 4 Carboxamide, Flu], supplied by Dr Ehrenstorfer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/fluxapyroxad++3++difluoromethyl++1+methyl+n++3++4++5+trifluorobiphenyl+2+yl++pyrazole+4+carboxamide++flu+/pm35864390-32-3-13
Average 90 stars, based on 1 article reviews
fluxapyroxad [3-(difluoromethyl)-1-methyl-n-(3′,4′,5′trifluorobiphenyl-2-yl) pyrazole-4-carboxamide, flu] - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
cis-a4-prostaglandin flu methyl ester (4)  (Pharmacia Upjohn LLC)
90
Pharmacia Upjohn LLC cis-a4-prostaglandin flu methyl ester (4)
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Cis A4 Prostaglandin Flu Methyl Ester (4), supplied by Pharmacia Upjohn LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/cis+a4+prostaglandin+flu+methyl+ester++4+/10__1021_slash_jo01307a014-233-34-22
Average 90 stars, based on 1 article reviews
cis-a4-prostaglandin flu methyl ester (4) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
flu/arac/amsa/tbi 4 gy/atg/cyclo  (Schmid GmbH)
90
Schmid GmbH flu/arac/amsa/tbi 4 gy/atg/cyclo
(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) <t>EIDD-2749,</t> (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.
Flu/Arac/Amsa/Tbi 4 Gy/Atg/Cyclo, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+flu/flu+arac+amsa+tbi+4+gy+atg+cyclo/pm19561407-48-94-87
Average 90 stars, based on 1 article reviews
flu/arac/amsa/tbi 4 gy/atg/cyclo - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
5-chloro-n-[4-[[2,3-dihydro-5-(methoxymethyl)-1-methyl-3-oxo-2-phenyl-1h-pyrazol-4-yl]amino]-2,2-dimethyl-4-oxobutyl]-2-ethoxy-4-flu oro-benzamide  (Biosynth Carbosynth)
N/A
   Buy from Supplier

Image Search Results


(A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) EIDD-2749, (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.

Journal: Cell reports

Article Title: De novo recovery of Ghana virus, an African bat Henipavirus, reveals differential tropism and attenuated pathogenicity compared to Nipah virus

doi: 10.1016/j.celrep.2026.117074

Figure Lengend Snippet: (A–E) Dose-response curves are shown for various small-molecule inhibitors against rGhV M-GS* (purple) and rNiV (orange). CHO-B2 cells were infected at an MOI of 0.05 and treated with (A) EIDD-2749, (B) GHP-88309, (C) remdesivir, (D) EIDD-1931 (molnupiravir active form), or (E) favipiravir (T-705). (F and G) Additional dose-response curves were measured in primary human astrocytes for (F) EIDD-2749 and (G) GHP-88309 under the same MOI and assay conditions. (H) Summary of half-maximal inhibitory concentrations (IC 50 ) derived from the dose-response curves in (A–G). Each row indicates the respective compound, virus, calculated IC 50 , corresponding 95% confidence interval, and the cell type in which the assay was performed. IC 50 values were determined in GraphPad Prism by nonlinear regression of (inhibitor) vs. normalized response. All experiments were conducted in biological triplicate. Error bars depict standard deviation.

Article Snippet: EIDD-2749 (4′-Fluorouridine) , MedChemExpress , Cat# HY-146246.

Techniques: Infection, Derivative Assay, Virus, Standard Deviation